Advertisement

Topics

Study allays concerns over aspirin's safety for heart failure patients

19:05 EDT 31 Jul 2017 | Science Daily

A new study allays concerns among cardiologists that aspirin could increase the risk of hospitalization and death related to heart failure for patients with heart failure who take one of the first-line therapies: angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs).

Original Article: Study allays concerns over aspirin's safety for heart failure patients

NEXT ARTICLE

More From BioPortfolio on "Study allays concerns over aspirin's safety for heart failure patients"

Quick Search
Advertisement